Skip to main content
eScholarship
Open Access Publications from the University of California

Efficacy, safety, tolerability and pharmacokinetics of a novel human immune globulin subcutaneous, 20%: a Phase 2/3 study in Europe in patients with primary immunodeficiencies

  • Author(s): Borte, M
  • Krivan, G
  • Derfalvi, B
  • Marodi, L
  • Harrer, T
  • Jolles, S
  • Bourgeois, C
  • Engl, W
  • Leibl, H
  • McCoy, B
  • Gelmont, D
  • Yel, L
  • et al.

Published Web Location

https://doi.org/10.1111/cei.12866Creative Commons Attribution 4.0 International Public License
Main Content
Current View